7-137463530-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001321708.2(DGKI):āc.2694G>Cā(p.Glu898Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00033 in 1,614,056 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001321708.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGKI | NM_001321708.2 | c.2694G>C | p.Glu898Asp | missense_variant | 27/33 | ENST00000614521.2 | NP_001308637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGKI | ENST00000614521.2 | c.2694G>C | p.Glu898Asp | missense_variant | 27/33 | 5 | NM_001321708.2 | ENSP00000479053 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000143 AC: 36AN: 251404Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135864
GnomAD4 exome AF: 0.000347 AC: 507AN: 1461872Hom.: 0 Cov.: 31 AF XY: 0.000322 AC XY: 234AN XY: 727238
GnomAD4 genome AF: 0.000171 AC: 26AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.2718G>C (p.E906D) alteration is located in exon 28 (coding exon 28) of the DGKI gene. This alteration results from a G to C substitution at nucleotide position 2718, causing the glutamic acid (E) at amino acid position 906 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at